Article

Diabetic ketoacidosis in pregnancy.

Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, The University of Texas Health Science Center in San Antonio, San Antonio, TX 78229, USA.
Obstetrics and Gynecology Clinics of North America (Impact Factor: 1.4). 10/2007; 34(3):533-43, xii. DOI: 10.1016/j.ogc.2007.08.001
Source: PubMed

ABSTRACT Episodes of diabetic ketoacidosis (DKA) can represent a life-threatening emergency for mother and fetus. The cornerstones of treatment of DKA are aggressive fluid replacement and insulin administration while ascertaining which precipitating factors brought about the current episode of DKA, and then treating accordingly to mitigate those factors. The incidence of DKA and factors unique to pregnancy are discussed in this article, along with the effects of the disease process on pregnancy. Clinical presentation, diagnosis, and treatment modalities are covered in detail to offer ideas to improve maternal and fetal outcome.

2 Followers
 · 
136 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Three cases of ketosis decompensation occurring immediately in type I diabetic after corticotherapy for lung foetal maturation (LFM) are reported. Few of observations have been published. Increasing doses of insulin is mandatory under close monitoring of blood glucose levels, in particular according to the protocol proposed by Kaushal et al.: infusion of insulin adapted to the results of glucose levels, as a supplementation to the usual doses in each patient. Diabetes does not lead to hesitate prescribing a corticotherapy for LFM, but requires a strict control of needs in insulin to avoid a ketosis decompensation.
    Journal de Gynécologie Obstétrique et Biologie de la Reproduction 01/2013; DOI:10.1016/j.jgyn.2013.08.012 · 0.62 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The purpose of this review is to understand new modalities available to treat and manage type 1 and type 2 diabetes during pregnancy. The use of new insulin analogs and oral agents, as well as new technologies to deliver insulin and monitor glucose during pregnancy remains controversial. This review will outline the advantages and disadvantages, as well as the safety profiles of these new medications and therapeutic options. There are many effective treatments for diabetes during pregnancy. New insulin analogs seem to be safe to use in pregnancy and offer the potential for better glycemic control compared with older agents. Oral hypoglycemic medications also seem to be safe and may be an option for a select group of pregnant patients with type 2 diabetes. Insulin pumps and continuous glucose monitoring systems may be beneficial in certain patients, but adequate data are not yet available in terms of outcomes and cost-effectiveness to support widespread use. Obstetricians & Gynecologists, Family Physicians After participating in this CME activity, physicians should be better able to revise glycemic goals for pregnant patients with pregestational diabetes to be in line with our current understanding of glycemic profiles in normal pregnant women. Use new insulin analogs to treat pregnant women with abnormalities in glucose homeostasis and choose which patients will benefit from advanced technologies for diabetes management, such as insulin pumps and continuous glucose monitoring systems.
    Obstetrical & gynecological survey 03/2012; 67(3):167-75. DOI:10.1097/OGX.0b013e31824bb538 · 2.36 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Three cases of ketosis decompensation occurring immediately in type I diabetic after corticotherapy for lung foetal maturation (LFM) are reported. Few of observations have been published. Increasing doses of insulin is mandatory under close monitoring of blood glucose levels, in particular according to the protocol proposed by Kaushal et al.: infusion of insulin adapted to the results of glucose levels, as a supplementation to the usual doses in each patient. Diabetes does not lead to hesitate prescribing a corticotherapy for LFM, but requires a strict control of needs in insulin to avoid a ketosis decompensation.
    Journal de Gynécologie Obstétrique et Biologie de la Reproduction 09/2013; · 0.62 Impact Factor